Figure 1.
A flow chart of the trial.
Table 1.
Patient characteristics.
Table 2.
Adverse events.
Figure 2.
Time to recurrence in patients in the adjuvant 125I brachytherapy vs. in the control group, log-rank, X2 = 7.04, p = 0.008.
Table 3.
Univariate analyses of the recurrence- and OS-related factors.
Table 4.
Multivariate analyses of the recurrence- and OS-related factors.
Figure 3.
OS in patients in the adjuvant 125I brachytherapy vs. in the control group, log-rank, X2 = 4.97, p = 0.026.